Aurinia Pharmaceuticals
AUPH
#4602
Rank
S$2.68 B
Marketcap
S$20.35
Share price
0.38%
Change (1 day)
66.17%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): S$0.10 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.26 Billion. In 2024 the company made an earning of S$15.93 Million, an increase over its 2023 earnings that were of -S$96.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.10 B587.13%
2024 S$15.93 M-116.44%
2023 -S$96.93 Million-31.8%
2022 -S$0.15 Billion-39.4%
2021 -S$0.24 Billion61.9%
2020 -S$0.15 Billion-9.73%
2019 -S$0.17 Billion92.65%
2018 -S$83.3 Million36.39%
2017 -S$61.08 Million106.29%
2016 -S$29.61 Million-15.4%
2015 -S$35 Million65.84%
2014 -S$21.1 Million129.82%
2013 -S$9.19 Million-26.6%
2012 -S$12.51 Million
2010 -S$7.09 Million-39.22%
2009 -S$11.66 Million-43.78%
2008 -S$20.73 Million-53.19%
2007 -S$44.28 Million42.97%
2006 -S$30.98 Million-23.03%
2005 -S$40.25 Million36.1%
2004 -S$29.57 Million172.57%
2003 -S$10.85 Million484.61%
2002 -S$1.86 Million
2000 -S$8.82 Million453.81%
1999 -S$1.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$6.67 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-S$7.12 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-S$28.71 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA